- Current report filing (8-K)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 18, 2009

 

REMEDENT, INC.

(Exact name of registrant as specified in its charter)

 

 

Nevada (State or Other Jurisdiction of Incorporation)

001-15975 (Commission File Number)

86-0837251 (IRS Employer Identification No.)

 

Xavier de Cocklaan 42, 9831, Deurle, Belgium (Address of Principal Executive Offices)		N/A (Zip Code)

 

 

011-329-321-70-80

(Registrant's telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

1

 

 

---

 

Section 2 – Financial Information

 

Item 2.02 Results of Operations and Financial Condition.

 

          On February 23, 2009, the Company issued a press release reporting its financial results for the quarter ended December 31, 2008.

 

          A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Section 7 - Regulation FD

 

Item 7.01. Regulation FD Disclosure

 

          On February 18, 2009 , the Company issued a press release announcing its Third Fiscal Quarter Conference Call for Tuesday, February 24, 2009.

 

A copy of the press release is attached hereto as Exhibit 99.2 and incorporated herein by reference.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

(d)	Exhibits .

 

Exhibit No.	Exhibit Description
99.1	Press Release dated February 23, 2009 announcing financial results for the quarter ended December 31, 2008
99.2	Press Release dated February 18, 2009 announcing third fiscal quarter conference call

The information set forth under Items 2.02 and 7.01 of this Form 8-K and Exhibits 99.1 and 99.2 attached hereto are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act of 1934 or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation by reference language in any filing.

 

Portions of this report constitute “forward-looking statements” defined by federal law. Although the Company believes any such statements are based on reasonable assumptions, there is no assurance that the actual outcomes will not be materially different. Any such statements are made in reliance on the “safe harbor” protections provided under the Private Securities Litigation Reform Act of 1995. Additional information about issues that could lead to material changes in the Company’s performance is contained in the Company’s filings with the Securities and Exchange Commission and may be accessed at www.sec.gov.

 

2

 

 

---

 

SIGNATURE

 

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

REMEDENT, INC. ,

a Nevada corporation

 

 

Dated:

February 23, 2009

By:  /s/ Stephen Ross

Stephen Ross

Chief Financial Officer

 

 

3